New treatment for bronchiectasis

New treatment for bronchiectasis

Bronchiectasis is a lung condition where the bronchi (lung branches) are damaged and therefore cannot clear themselves. This causes inflammation, leading to infections in the airways. It also prevents individuals from breathing easily. There is no known cure for the lung condition bronchiectasis, however, a new treatment for bronchiectasis is being trialled by our Clinical Trials Unit.

Our staff in the clinical trials unit are currently calling for volunteers to participate in clinical research trials aimed to achieve improvements in bronchiectasis treatment.

Acting Head of the Clinical Trials Unit, Felicite Kelsall urges anyone who has had a diagnosis of bronchiectasis to contact them to confirm their eligibility to be a participant in this trial.

“We need to learn more about bronchiectasis and being part of a clinical trial can help us to find better treatments for this condition,” she said.

We also conduct clinical trials for a number of other respiratory illnesses including asthma, COPD/emphysema, cystic fibrosis, idiopathic pulmonary fibrosis, and alpha 1-antitrypsin deficiency.

If you live with bronchiectasis, or any of the other mentioned respiratory conditions, and want to help to find answers please call our friendly team on (08) 6457 3198, email admin@resphealth.uwa.edu.au or fill out our online form.

New treatment for bronchiectasis was last modified: September 13th, 2018 by Sarah Cermak